Pfizer, Hydra strike $195M pain pact - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News

Pfizer, Hydra strike $195M pain pact - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News: "Cambridge, MA-based Hydra Biosciences has struck a deal with Pfizer Global Research & Development to collaborate on new pain therapies. Hydra stands to gain up to $195 million in up front and milestone payments--there's no breakdown on the numbers--for the first product developed from the Transient Receptor Potential channel family. Pfizer will fund all research and development work and gains exclusive commercialization rights to any product developed in the collaboration."